Article
Determination of dose enhancement caused by AuNPs with Xoft® Axxent® Electronic (eBx™) and…
International Journal of Nanomedicine · 2018 · Shahhoseini E, Ramachandran P, Patterson WR, Geso M
Key facts
| Title | Determination of dose enhancement caused by AuNPs with Xoft® Axxent® Electronic (eBx™) and conventional brachytherapy: in vitro study |
|---|---|
| First author | Shahhoseini E, Ramachandran P, Patterson WR, Geso M |
| Journal | International Journal of Nanomedicine |
| Published | Sep 25, 2018 |
| DOI | 10.2147/IJN.S174624 |
| Devices mentioned | K001825, K021286, K041715, K041933, K050843, K060532, K061354, K070574, K072616, K072683, K083734, K090417 and 12 more |
| Product codes mentioned | IXI, JAD, JAQ, IWJ, KXK, KPT |
At a glance
- 10–99 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1